MMP3
Basic information
Region (hg38): 11:102835801-102843609
Previous symbols: [ "STMY1", "STMY" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMP3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | |||||
missense | 28 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 2 | ||||
non coding | 14 | 15 | ||||
Total | 0 | 0 | 28 | 8 | 24 |
Variants in MMP3
This is a list of pathogenic ClinVar variants found in the MMP3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-102836175-G-C | not specified | Uncertain significance (Apr 13, 2022) | ||
11-102836574-G-A | Benign (Nov 12, 2018) | |||
11-102837183-A-G | Benign (Nov 12, 2018) | |||
11-102837312-A-G | not specified | Uncertain significance (Jun 24, 2022) | ||
11-102837326-T-C | Likely benign (May 17, 2018) | |||
11-102837331-C-A | not specified | Uncertain significance (Jan 07, 2022) | ||
11-102837357-T-C | not specified | Uncertain significance (Feb 26, 2024) | ||
11-102838611-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
11-102838615-C-T | not specified | Uncertain significance (Jul 27, 2022) | ||
11-102838649-G-A | Benign (Jul 15, 2018) | |||
11-102838654-T-A | not specified | Uncertain significance (Jul 19, 2022) | ||
11-102838694-A-G | not specified | Benign (Nov 12, 2018) | ||
11-102838730-CAG-C | Benign (Nov 12, 2018) | |||
11-102838791-T-A | Benign (Nov 12, 2018) | |||
11-102839154-G-T | not specified | Uncertain significance (Apr 12, 2024) | ||
11-102839190-G-T | not specified | Uncertain significance (May 24, 2023) | ||
11-102839209-G-A | not specified | Uncertain significance (May 09, 2023) | ||
11-102839216-C-A | not specified | Uncertain significance (Apr 07, 2022) | ||
11-102839352-G-A | Benign (Jun 21, 2021) | |||
11-102839976-T-A | Benign (Nov 12, 2018) | |||
11-102840185-C-A | Benign (Jul 23, 2018) | |||
11-102840213-G-A | not specified | Uncertain significance (Oct 20, 2021) | ||
11-102840228-G-T | not specified | Uncertain significance (Feb 13, 2024) | ||
11-102840234-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
11-102840251-T-C | MMP3-related disorder | Benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMP3 | protein_coding | protein_coding | ENST00000299855 | 10 | 8003 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.74e-15 | 0.0146 | 125591 | 0 | 155 | 125746 | 0.000617 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.644 | 285 | 256 | 1.11 | 0.0000128 | 3136 |
Missense in Polyphen | 94 | 80.177 | 1.1724 | 1004 | ||
Synonymous | -1.38 | 114 | 96.8 | 1.18 | 0.00000515 | 920 |
Loss of Function | 0.0341 | 22 | 22.2 | 0.992 | 0.00000112 | 275 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00221 | 0.00220 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000926 | 0.000925 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000364 | 0.000360 |
Middle Eastern | 0.000926 | 0.000925 |
South Asian | 0.00115 | 0.00114 |
Other | 0.000983 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates procollagenase.;
- Disease
- DISEASE: Coronary heart disease 6 (CHDS6) [MIM:614466]: A multifactorial disease characterized by an imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. Decreased capacity of the coronary vessels is often associated with thickening and loss of elasticity of the coronary arteries. {ECO:0000269|PubMed:12477941, ECO:0000269|PubMed:8662692}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A polymorphism in the MMP3 promoter region is associated with the risk of coronary heart disease and myocardial infarction, due to lower MMP3 proteolytic activity and higher extracellular matrix deposition in atherosclerotic lesions.;
- Pathway
- TNF signaling pathway - Homo sapiens (human);Prostate cancer - Homo sapiens (human);IL-17 signaling pathway - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Matrix Metalloproteinases;Oncostatin M Signaling Pathway;Photodynamic therapy-induced NF-kB survival signaling;Protein alkylation leading to liver fibrosis;Interleukin-4 and 13 signaling;Signaling by GPCR;Assembly of collagen fibrils and other multimeric structures;Signal Transduction;Collagen degradation;Collagen formation;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Degradation of the extracellular matrix;EGFR Transactivation by Gastrin;Posttranslational regulation of adherens junction stability and dissassembly;Gastrin-CREB signalling pathway via PKC and MAPK;G alpha (q) signalling events;GPCR downstream signalling;p75(NTR)-mediated signaling;Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
(Consensus)
Recessive Scores
- pRec
- 0.866
Intolerance Scores
- loftool
- 0.898
- rvis_EVS
- -0.66
- rvis_percentile_EVS
- 15.91
Haploinsufficiency Scores
- pHI
- 0.127
- hipred
- N
- hipred_score
- 0.182
- ghis
- 0.416
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.589
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mmp3
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype;
Gene ontology
- Biological process
- proteolysis;negative regulation of hydrogen peroxide metabolic process;cytokine-mediated signaling pathway;extracellular matrix disassembly;extracellular matrix organization;collagen catabolic process;positive regulation of protein oligomerization;cellular response to nitric oxide;regulation of neuroinflammatory response;positive regulation of oxidative stress-induced cell death
- Cellular component
- extracellular region;extracellular space;extracellular matrix
- Molecular function
- endopeptidase activity;metalloendopeptidase activity;serine-type endopeptidase activity;protein binding;metallopeptidase activity;zinc ion binding